Inside PAREXEL: Genomic Medicine

November 1, 2016
PAREXEL’s Anita Nelsen explains how the influence of genomic and pharmacogenomics information in clinical research helps make better drugs and gets those drugs to the right patients. Regulators are also interested in pharmacogenomic information to support drug development decisions. In fact, they’re recommending that companies collect and retain pharmacogenomic samples, even after the clinical studies are done. Sometimes safety questions arise after a drug has already gone to market. By leveraging banked pharmacogenomic samples, we can help clients answer those questions. Learn more at parexel.com Anita Nelsen, Head of Genomic Medicine, Senior Director, PAREXEL International
Previous Video
Inside PAREXEL: Protocol Optimization
Inside PAREXEL: Protocol Optimization

PAREXEL uses protocol optimization to provide an innovative approach to clinical trial process. Sy Pretoriu...

Next Video
ClinPhone® RTSM Mobile App
ClinPhone® RTSM Mobile App

Reduce site administration, improve data accuracy and patient safety. The ClinPhone® RTSM mobile app is des...